Related references
Note: Only part of the references are listed.Synthesis of novel glutarimide ligands for the E3 ligase substrate receptor Cereblon (CRBN): Investigation of their binding mode and antiproliferative effects against myeloma cell lines
Mikhail Krasavin et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)
High-resolution structures of the bound effectors avadomide (CC-122) and iberdomide (CC-220) highlight advantages and limitations of the MsCI4 soaking system
Christopher Heim et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2022)
A Versatile and Sustainable Multicomponent Platform for the Synthesis of Protein Degraders: Proof-of-Concept Application to BRD4-Degrading PROTACs
Irene Preet Bhela et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
SJPYT-195: A Designed Nuclear Receptor Degrader That Functions as a Molecular Glue Degrader of GSPT1
Andrew D. Huber et al.
ACS MEDICINAL CHEMISTRY LETTERS (2022)
The E3 ligase adapter cereblon targets the C-terminal cyclic imide degron
Saki Ichikawa et al.
NATURE (2022)
Identification and structural basis of C-terminal cyclic imides as natural degrons for cereblon
Christopher Heim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)
Development of the first non-hydroxamate selective HDAC6 degraders
Tim Keuler et al.
CHEMICAL COMMUNICATIONS (2022)
Targeting the deubiquitinase USP7 for degradation with PROTACs
Arunima Murgai et al.
CHEMICAL COMMUNICATIONS (2022)
E3 ligase ligand chemistries: from building blocks to protein degraders
Izidor Sosic et al.
CHEMICAL SOCIETY REVIEWS (2022)
On the correlation of cereblon binding, fluorination and antiangiogenic properties of immunomodulatory drugs
Christopher Heim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
Sweet and Blind Spots in E3 Ligase Ligand Space Revealed by a Thermophoresis-Based Assay
Samuel Maiwald et al.
ACS MEDICINAL CHEMISTRY LETTERS (2021)
Petasis vs. Strecker Amino Acid Synthesis: Convergence, Divergence and Opportunities in Organic Synthesis
Wayiza Masamba
MOLECULES (2021)
Development of MDM2 degraders based on ligands derived from Ugi reactions: Lessons and discoveries
Bo Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Identification of Potent, Selective, and Orally Bioavailable Small-Molecule GSPT1/2 Degraders from a Focused Library of Cereblon Modulators
Gisele Nishiguchi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Acute pharmacological degradation of Helios destabilizes regulatory T cells
Eric S. Wang et al.
NATURE CHEMICAL BIOLOGY (2021)
Room-Temperature Cu(II) Radical-Triggered Alkyne C-H Activation
Jack Devonport et al.
JACS AU (2021)
Selective Degradation of GSPT1 by Cereblon Modulators Identified via a Focused Combinatorial Library
Chelsea E. Powell et al.
ACS CHEMICAL BIOLOGY (2020)
diaPASEF: parallel accumulation-serial fragmentation combined with data-independent acquisition
Florian Meier et al.
NATURE METHODS (2020)
Systematic exploration of different E3 ubiquitin ligases: an approach towards potent and selective CDK6 degraders
Christian Steinebach et al.
CHEMICAL SCIENCE (2020)
Chemoselective Synthesis of Lenalidomide-Based PROTAC Library Using Alkylation Reaction
Xing Qiu et al.
ORGANIC LETTERS (2019)
De-Novo Design of Cereblon (CRBN) Effectors Guided by Natural Hydrolysis Products of Thalidomide Derivatives
Christopher Heim et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Reactivity and Synthetic Applications of Multicomponent Petasis Reactions
Peng Wu et al.
CHEMICAL REVIEWS (2019)
Discovery of ARD-69 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor (AR) for the Treatment of Prostate Cancer
Xin Han et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Mechanism of Action and Novel IMiD-Based Compounds and Combinations in Multiple Myeloma
Ajay K. Nooka et al.
CANCER JOURNAL (2019)
PROTAC-mediated crosstalk between E3 ligases
Christian Steinebach et al.
CHEMICAL COMMUNICATIONS (2019)
A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos
Mary E. Matyskiela et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Chemical probes and drug leads from advances in synthetic planning and methodology
Christopher J. Gerry et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Homo-PROTACs for the Chemical Knockdown of Cereblon
Christian Steinebach et al.
ACS CHEMICAL BIOLOGY (2018)
Chemical Ligand Space of Cereblon
Iuliia Boichenko et al.
ACS OMEGA (2018)
BET Bromodomain Proteins Function as Master Transcription Elongation Factors Independent of CDK9 Recruitment
Georg E. Winter et al.
MOLECULAR CELL (2017)
Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4
Jing Lu et al.
CHEMISTRY & BIOLOGY (2015)
Lenalidomide induces ubiquitination and degradation of CK1a in del(5q) MDS
Jan Kroenke et al.
NATURE (2015)
Synthesis of BODIPY Derivatives Substituted with Various Bioconjugatable Linker Groups: A Construction Kit for Fluorescent Labeling of Receptor Ligands
Fabian Heisig et al.
JOURNAL OF FLUORESCENCE (2014)
Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
Jan Kroenke et al.
SCIENCE (2014)
Chemistry and Biology Of Multicomponent Reactions
Alexander Domling et al.
CHEMICAL REVIEWS (2012)
Selective inhibition of BET bromodomains
Panagis Filippakopoulos et al.
NATURE (2010)
On the use of boronates in the Petasis reaction
H Jourdan et al.
TETRAHEDRON LETTERS (2005)